Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have been given a consensus recommendation of “Hold” by the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and two have given a strong buy rating to the company.
Several research analysts recently commented on SAUHY shares. UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a research note on Tuesday, November 4th. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. Citigroup reissued a “sell” rating on shares of Straumann in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st. Finally, The Goldman Sachs Group downgraded shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research note on Monday, October 13th.
Get Our Latest Report on SAUHY
Straumann Stock Down 0.2%
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Further Reading
- Five stocks we like better than Straumann
- Wall Street Stockpicker Names #1 Stock of 2026
- The McDonald’s Secret
- $4,200 gold is nice … but here’s what most gold bugs are missing
- Trump’s $500B plan is fueling these monthly dividends
- How Long Will $1M Last in Retirement?
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
